MDMA or related drug-induced delirium, including MDA (Q40432): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Delirium induzido por MDMA ou drogas relacionadas, incluindo MDA é caracterizado por um estado agudo de perturbação da atenção e consciência com características específicas de delirium, que se desenvolve durante ou logo após intoxicação pela substância ou durante o uso de MDMA ou drogas relacionadas. A quantidade e a duração do uso de MDMA ou drogas relacionadas devem ser capazes de produzir delirium. Os sintomas não são mais bem explicados por um transtorno mental primário ou pelo uso ou abstinência de uma substância diferente, ou por outra condição de saúde que não esteja classificada como transtornos mentais, comportamentais e do neurodesenvolvimento. | |||||||||||||||
| description / en | description / en | ||||||||||||||
MDMA or related drug-induced delirium, including MDA is characterised by an acute state of disturbed attention and awareness with specific features of delirium that develops during or soon after substance intoxication or during the use of MDMA or related drugs. The amount and duration of MDMA or related drug use must be capable of producing delirium. The symptoms are not better explained by a primary mental disorder, by use of or withdrawal from a different substance, or by another health condition that is not classified under Mental, behavioural and neurodevelopmental disorders. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1828722493 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:6C4C.5 | |||||||||||||||
| Property / CURIE: CID11:6C4C.5 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-6C4C.5 | |||||||||||||||
| Property / Canary Token: dki-india-6C4C.5 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: F15.4 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 06:14, 13 August 2026
MDMA or related drug-induced delirium, including MDA is characterised by an acute state of disturbed attention and awareness with specific features of delirium that develops during or soon after substance intoxication or during the use of MDMA or related drugs. The amount and duration of MDMA or related drug use must be capable of producing delirium. The symptoms are not better explained by a primary mental disorder, by use of or withdrawal from a different substance, or by another health condition that is not classified under Mental, behavioural and neurodevelopmental disorders.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 6C4C.5 |
||
| English | MDMA or related drug-induced delirium, including MDA |
MDMA or related drug-induced delirium, including MDA is characterised by an acute state of disturbed attention and awareness with specific features of delirium that develops during or soon after substance intoxication or during the use of MDMA or related drugs. The amount and duration of MDMA or related drug use must be capable of producing delirium. The symptoms are not better explained by a primary mental disorder, by use of or withdrawal from a different substance, or by another health condition that is not classified under Mental, behavioural and neurodevelopmental disorders. |
Statements
CID11:6C4C.5
0 references
dki-india-6C4C.5
0 references
Concluído
0 references
13 August 2026
0 references
